Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Lycopene. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103553916A reveals a streamlined Wittig-Horner route for C15 acetate, offering significant cost reduction in pharma intermediate manufacturing and scalable production.
Novel synthesis of 1,4,6,10-tetradouble-bond pentadecyl phosphonate via Wittig-Horner reaction. Offers cost-effective, scalable route for high-purity lycopene production.
Novel Wittig route for apo-8'-lycopene reduces steps and enhances supply chain stability for global buyers seeking high purity intermediates.
Patent CN105622376B details a safer Wittig route for apo-8'-lycopene. This method offers significant supply chain stability and cost efficiency for nutritional ingredient manufacturing.
Novel Darzens condensation method for lycopene intermediate ensures high purity and cost efficiency. Reliable supply chain solution for pharmaceutical manufacturing.